Literature DB >> 19781479

Perioperative management of anticoagulated patients having cataract surgery: National audit of current practice of members of the Royal College of Ophthalmologists.

Ruchika Batra1, Anna Maino, Sun W Ch'ng, Ian B Marsh.   

Abstract

An 11-item questionnaire was mailed to 891 consultant members of the Royal College of Ophthalmologists (RCOphth) to audit compliance with RCOphth guidelines for perioperative management of anticoagulated patients having cataract surgery. Four hundred ninety-nine questionnaires were analyzed. The results showed that 29.5% of respondents adhered to all aspects of RCOphth guidelines; that is, they checked the international normalized ratio (INR) preoperatively, continued warfarin, operated within the desired therapeutic INR range for the condition that warfarin was being used to treat (as set by the treating physician), and considered sub-Tenon or topical anesthesia in anticoagulated patients.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19781479     DOI: 10.1016/j.jcrs.2009.05.042

Source DB:  PubMed          Journal:  J Cataract Refract Surg        ISSN: 0886-3350            Impact factor:   3.351


  4 in total

1.  Peribulbar anesthesia in 750 patients treated with oral anticoagulants.

Authors:  Emile Calenda; Olivier Genevois; Annie Cardon; Marc Muraine
Journal:  Int J Ophthalmol       Date:  2014-02-18       Impact factor: 1.779

2.  Safety of cataract surgery in patients treated with the new oral anticoagulants (NOACs).

Authors:  Irina S Barequet; Tzukit Zehavi-Dorin; Nirit Bourla; Ilia Tamarin; Joseph Moisseiev; Ophira Salomon
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2019-10-22       Impact factor: 3.117

Review 3.  Peri-operative management of ophthalmic patients on anti-thrombotic agents: a literature review.

Authors:  A K Makuloluwa; S Tiew; M Briggs
Journal:  Eye (Lond)       Date:  2019-03-08       Impact factor: 3.775

Review 4.  The Dilemma of Peri-Procedural Warfarin Management: A Narrative Review.

Authors:  Islam Eljilany; Ahmed El-Bardissy; Hazem Elewa
Journal:  Clin Appl Thromb Hemost       Date:  2021 Jan-Dec       Impact factor: 2.389

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.